Assessing the effect of multiple doses of zibotentan on the pharmacokinetics of single doses of combined oral contraceptives in healthy female participants of non-childbearing potential.

Trial Identifier: D4325C00006
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05505162
Start Date: August 2022
Primary Completion Date: January 2023
Study Completion Date: January 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225